{
    "2021-10-22": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Eli Lilly (LLY) Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Gains",
                        "Market Dips"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Should You Buy Eli Lilly and Company (LLY) Ahead of Earnings?",
                "features": {
                    "keywords": [
                        "Buy",
                        "Eli Lilly",
                        "Earnings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Will Merck's COVID-19 Pill Sink Regeneron's and Eli Lilly's Antibody Therapy Sales?",
                "features": {
                    "keywords": [
                        "Merck",
                        "COVID-19 Pill",
                        "Regeneron",
                        "Eli Lilly",
                        "Antibody Therapy",
                        "Sales"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}